
Martin Douglas Fleming MD
Breast Cancer, Melanoma, Sarcoma
Professor, Surgery, University of Tennessee, Memphis, College of Medicine Chief, Division of Surgical Oncology
Join to view full profile
7705 Poplar AveSte 220Germantown, TN 38138
Phone+1 901-516-6792
Fax+1 901-266-6422
Dr. Fleming is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Martin Fleming, MD, is a surgical oncologist based in Memphis, TN, with subspecialty expertise in the surgical treatment of melanoma and other cutaneous malignancies, soft tissue sarcoma, and breast cancer. He completed his surgery residency at the University of Texas Southwestern Medical Center in 1991 and graduated from the University of Tennessee Health Science Center College of Medicine in 1986. He completed his surgical oncology fellowship at the Medical College of Virginia. Dr. Fleming has considerable experience in breast surgery and non-breast surgical oncology. His recent publications focus on molecular aspects of breast cancer and melanoma, having been featured in prestigious journals such as Proceedings of the National Academy of Sciences and Cell Reports. Notable recognition includes being a Fellow of the American College of Surgeons (FACS).
Education & Training
University of Texas Southwestern Medical CenterResidency, Surgery, 1986 - 1991
University of Tennessee Health Science Center College of MedicineClass of 1986
Certifications & Licensure
MS State Medical License 2013 - 2027
TN State Medical License 1993 - 2027
AR State Medical License 2013 - 2021
TX State Medical License 1987 - 1991
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart (Image Results), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- 2 citationsNeoadjuvant Chemoradiation Versus Chemotherapy for Esophageal Cancer: A Histology-Stratified Update Meta-Analysis of Randomized Controlled Trials.Andrew M Fleming, Brenden Sheridan, Angel Doño, Theresa Dinh, Logan Meyer
Annals of Surgical Oncology. 2026-05-01 - Specificity of Celbrea, a novel noninvasive thermal screening device, in women with recent negative screening mammograms.Nickolas Stabellini, Ashley Hendrix, Lisa McKnight, Linnea Cripe, Alejandra Alvarez
Frontiers in Oncology. 2026-01-01 - Setting Global Surgery Standards in Education, Credentialing and Licensing.Nia Zalamea, Martin Fleming, Maria Cecilia Tagle Leyson
The Surgical Clinics of North America. 2025-12-01
Press Mentions
UTHSC Extends Reach to Advance Health Equity Locally and GloballyJune 4th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: